Using Analytics to Maximize Copay Program Effectiveness
With respect to patient access to care programs, manufacturers have been content to receive data on the numbers of redemptions, patients, and prescribers participating. As the copay industry has matured, these measures have become less and less adequate in supporting the brand team needs for robust ROI driving programs. Instead, pharmaceutical manufacturers are looking to analytics, with their rich sources of evidence, demonstrations of convincing payback, and sophisticated predictive models that include prescriber targeting, offer optimization, geographic analysis with big data. TrialCard provides an overview of the analytic data that we use to help our manufacturers to design the most effective campaigns and to assess their effectiveness. Download More Information | | |
You are subscribed as: kostikblog@ukr.net
